[1]
Gammazza, A.M., Campanella, C., Barone, R., Caruso Bavisotto, C., Gorska, M., Wozniak, M., Carini, F., Cappello, F., D’Anneo, A., Lauricella, M., Zummo, G., Conway De Macario, E., Macario, A.J. and Di Felice, V. 2017. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence. Italian Journal of Anatomy and Embryology. 121, 1 (Oct. 2017), 131.